Company intelligence
Adovate
Adenosine Innovation
Pharmaceutical Manufacturing
Charlottesville, US
11–50 employees
1 public signals
About Adovate
Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.
Verified activity
Signals from Adovate
1 published signal